Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB06643_DB08895_nanopub.RAKPYjUDtCJwBnnoDZZwQ4-_mtPldCyBfyJpoppdVpW1U#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB06643_DB08895 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB06643_DB08895 label "DDI between Denosumab and Tofacitinib - Denosumab, when used in combination with tofacitinib, may increase tofaciitinib toxicity and worsen side effects. It may specifically increase the risk of serious infection. It is recommended to monitor therapy. [drugbank_resource:DB06643_DB08895]" assertion.
- drugbank_resource:DB06643_DB08895 identifier "drugbank_resource:DB06643_DB08895" assertion.
- drugbank_resource:DB06643_DB08895 title "DDI between Denosumab and Tofacitinib - Denosumab, when used in combination with tofacitinib, may increase tofaciitinib toxicity and worsen side effects. It may specifically increase the risk of serious infection. It is recommended to monitor therapy." assertion.
- drugbank:DB08895 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06643_DB08895 assertion.
- drugbank:DB06643 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06643_DB08895 assertion.